Behcet Disease

17 registered clinical trials studyying Behcet Disease — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Cranial Nerve Functions in Behçet's Disease and Their Relationship With Clinical Parameters NCT07135063	Marmara University	—
Not Yet Recruiting	EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases NCT07077304	Assistance Publique - Hôpitaux de Paris	—
Not Yet Recruiting	Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet NCT06925698	Marmara University	Phase 3
Completed	Turkish Adaptation of the VascuQoL-6 Quality of Life Scale NCT06979245	Uşak University	—
Not Yet Recruiting	Evaluation of Voice in Behcet's NCT06836817	Minia University	—
Recruiting	BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008	Peking University People's Hospital	Phase 2
Recruiting	Quantification & Classification of Inflammatory Cells in Uveitis Using OCT NCT07065747	Oregon Health and Science University	—
Unknown	Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers NCT04186559	Silk Road Therapies, Inc.	Phase 2
Recruiting	Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases NCT05904301	Santé Arménie French-Armenian Research Center	—
Recruiting	Rheumatology Patient Registry and Biorepository NCT04402086	Yale University	—
Completed	Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic NCT04403438	Istanbul University	—
Completed	Pilates Based Exercises in Patients With Behçet and Familial Mediterranean Fever. NCT04402255	Istanbul University	N/A
Completed	Role of Regulatory B Cells in Behçet's Disease NCT04376411	Assiut University	—
Completed	1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement NCT02756650	Novartis Pharmaceuticals	Phase 2
Completed	A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intest NCT02505568	Janssen Korea, Ltd., Korea	Phase 3
Completed	Phase III Study in Refractory Behcet's Disease NCT00995709	Novartis Pharmaceuticals	Phase 3
Completed	Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease NCT00483184	Nobel Pharmaceuticals	Phase 2